BBI Historical PE Ratio image   This BBI PE ratio history page last updated 8/24/2022
BBI PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/11/2022
3.27-0.01-13.51NA
Q1 2022
5/12/2022
9.45-3.60-20.70NA
Q4 2021
3/15/2022
9.90-2.70-23.85NA
Q3 2021
11/9/2021
18.00-7.20-27.90NA
Q2 2021
8/12/2021
31.05-7.20-27.45NA
Q1 2021
5/13/2021
38.25-6.75-20.68NA
Q4 2020
3/9/2021
54.90-6.75-14.38NA
Q3 2020
11/12/2020
24.30-6.75-69.73NA
Q2 2020
8/12/2020
40.05-0.43-172.78NA
Q1 2020
5/13/2020
63.45-0.45NANA
Q4 2019
3/18/2020
51.30-62.10NANA
Q3 2019
11/13/2019
98.55-109.80NANA
BBI Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/11/2022
3.27-0.01-0.04NA
Q1 2022
5/12/2022
9.45-3.60-14.40NA
Q4 2021
3/15/2022
9.90-2.70-10.80NA
Q3 2021
11/9/2021
18.00-7.20-28.80NA
Q2 2021
8/12/2021
31.05-7.20-28.80NA
Q1 2021
5/13/2021
38.25-6.75-27.00NA
Q4 2020
3/9/2021
54.90-6.75-27.00NA
Q3 2020
11/12/2020
24.30-6.75-27.00NA
Q2 2020
8/12/2020
40.05-0.43-1.72NA
Q1 2020
5/13/2020
63.45-0.45-1.80NA
Q4 2019
3/18/2020
51.30-62.10-248.40NA
Q3 2019
11/13/2019
98.55-109.80-439.20NA
Quotes delayed 20 minutes

Email EnvelopeFree BBI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Brickell Biotech (BBI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BBIO PE Ratio History
BBLG PE Ratio History
BCAB PE Ratio History
BCDA PE Ratio History
BCEL PE Ratio History
BCLI PE Ratio History
BCRX PE Ratio History
BDSI PE Ratio History
BDSX PE Ratio History
BDTX PE Ratio History
On this page we presented the BBI PE Ratio History information for Brickell Biotech' stock. The average BBI PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BBI PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BBI PE ratio history result, against the recent PE: when this page was posted on 8/23/2022, the most recent closing price for BBI had been 2.98, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on BBI or any other given stock, valuation analysis for BBI can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Brickell Biotech PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for BBI. Thanks for visiting, and the next time you need to research BBI PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Top Ten Hedge Funds Holding OMED, SLF Average Annual Return, Funds Holding CHD.

 

BBI PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.